New endocrine approaches to breast cancer.
Howell
A
A
Dodwell
D J
DJ
Anderson
H
H
D000726:Androgen Antagonists / Q000494:pharmacology; D000818:Animals; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy*; D002064:Buserelin / Q000031:analogs & derivatives / Q000494:pharmacology; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000494:pharmacology; D017273:Goserelin; D006801:Humans; D008186:Luteolytic Agents / Q000494:pharmacology; D011372:Progestins / Q000037:antagonists & inhibitors / Q000494:pharmacology; D051381:Rats; D013004:Somatostatin / Q000031:analogs & derivatives; D017329:Triptorelin Pamoate
D000726:Androgen Antagonists; D047072:Aromatase Inhibitors; D004965:Estrogen Antagonists; D008186:Luteolytic Agents; D011372:Progestins; D017329:Triptorelin Pamoate; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone; D013004:Somatostatin; D002064:Buserelin